Pelareorep for treating relapsed or refractory multiple myeloma [ID1028]
Discontinued
Reference number: GID-TA10687
Following on from information provided to NICE by the company in May 2020 the appraisal of Pelareorep for treating relapsed or refractory multiple myeloma [ID1028] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.